Kauh John Saewook M.D. 4
4 · Tvardi Therapeutics, Inc. · Filed Apr 21, 2025
Insider Transaction Report
Form 4
Kauh John Saewook M.D.
Chief Medical Officer
Transactions
- Award
Employee Stock Option (right to buy)
2025-04-17+36,210→ 36,210 totalExercise: $17.04Exp: 2035-04-16→ Common Stock (36,210 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option shall vest on April 17, 2026, and the balance of the shares subject to the option shall vest in equal monthly installments over the following 36 months, subject to the Reporting Person's continuous service through each applicable vesting date.